Toxicity profile in cervical cancer patients receivingchemoradiation with concurrent parametrial boost

ABSTRACT

Introduction Radical surgery or chemoradiationtherapy is the options for treating early stagecervical cancer. The advanced stages are treatedwith radiation alone or concurrent chemoradiation.Concurrent cisplatinum based chemoradiation isconsidered the standard of care for carcinoma of thecervix and has shown a significantly improvedoverall survival and progression free survival inlocally advanced cancers. Despite improvedsurvival one third of the patients with advancedcancer of cervix have failure within two years. Socontinued improvement in treatment of advancedcervical cancer is needed. The concurrentparametrial boost with chemoradiation helps in locoregional control